TrkA antibody and application thereof
US12077591B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 25, 2023 |
| Grant date | Sep 3, 2024 |
| Priority date | — |
| Expiry date | May 25, 2043 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/2842
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides TrkA antibodies, compositions comprising such antibodies, and methods of using such antibodies for the prevention and/or treatment of a disease or disorder associated with an inappropriate expression or function of TrkA, such as pain.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.